11 views 0 likes

StayCurrentMD

GCMD Space · View profile →

Tricks - Ultrashort Segment Hirschsprungs - Kristine Thayer

Video Published 2018-11-10 Updated 2026-08-01

Timestops (6)

Topic Overview

A 16-year-old with trisomy 21 presented with lifelong constipation, stooling only twice monthly on MiraLAX. Initial suction rectal biopsy showed absent ganglion cells, but subsequent workup revealed conflicting pathology: a 3-cm transanal biopsy demonstrated hypertrophied nerve bundles and abnormal calretinin consistent with Hirschsprung disease, yet higher biopsies (5–7 cm transanally and laparoscopic colonic biopsies) all returned normal. Barium enema showed no transition zone. During workup, a 2-liter neurogenic bladder was discovered, raising concern for Hinman-Allen syndrome—a non-neurogenic neurogenic bladder with voluntary pelvic floor contraction seen in trisomy 21 adolescents. The surgeon performed a posterior myomectomy; pathology of the strip specimen confirmed aganglionosis from the anal verge to 2 cm, sparse ganglion cells from 2–4 cm, and normal ganglion cells beyond 4 cm, with hypertrophied nerves throughout. Post-myomectomy, the patient achieved spontaneous bowel movements and was managed with intermittent catheterization for the bladder dysfunction.

Key Takeaways

  • Suction rectal biopsy requires adequate submucosa, correct anatomic level, and calretinin staining for reliable Hirschsprung diagnosis. (1:10)
  • Conflicting pathology at different levels warrants anorectal manometry in cooperative patients to confirm physiologic obstruction. (3:02)
  • Hinman-Allen syndrome—non-neurogenic neurogenic bladder from voluntary pelvic floor contraction—is prevalent in trisomy 21 adolescents. (15:13)
  • Myomectomy for short-segment Hirschsprung often fails long-term, with increased obstructive symptoms and soiling risk. (17:00)
  • Strip myomectomy pathology showed aganglionosis 0-2 cm, sparse ganglion cells 2-4 cm, confirming ultrashort-segment disease. (13:44)

Inside this episode

Kai, the Library's AI content creator, listened to this episode and mapped who's speaking, the chapters, key claims, and cases. Every item links to the exact moment in the recording.

AI-enriched

Who's speaking

  • Kristine Thayer — guest
  • Jack — guest
  • Speaker 3 — host
  • Bob — guest
  • Sharif — guest
  • Speaker 6 — guest

Chapters

  • 0:00Case Presentation and Initial Workup — Presenter introduces a 16-year-old with trisomy 21 and lifelong constipation. Initial suction rectal biopsy showed no ganglion cells. Discussion of adequacy criteria for suction biopsies and decision to proceed with transanal full-thickness biopsy.
  • 2:57Pathology Results and Imaging — Transanal biopsy at 3 cm confirmed hypertrophied nerves and abnormal calretinin. Barium enema showed no transition zone. Additional biopsies obtained transanally (5, 6, 7 cm) and laparoscopically; all returned normal. Discussion of surgical approach in an adolescent.
  • 5:13Surgical Planning and Differential Diagnosis — Panel discusses whether to perform primary pull-through (Soave vs. Duhamel) versus diverting stoma in a 16-year-old. Discrepancy noted between severe symptoms (stooling twice monthly) and relatively normal-appearing colon. Botox injection proposed as diagnostic test.
  • 8:54Discovery of Neurogenic Bladder — All repeat biopsies (transanal and laparoscopic) returned normal. Patient found to have 2-liter neurogenic bladder with overflow incontinence. MRI of lumbar spine ordered to rule out tethered cord. Discussion of whether ultra-short segment Hirschsprung diagnosis remains valid.
  • 11:22Myomectomy and Final Pathology — Surgeon performed posterior strip myomectomy (22 cm × 6 cm) for diagnostic and therapeutic purposes. Pathology showed aganglionosis from verge to 2 cm, sparse ganglion cells 2–4 cm, normal ganglion cells 4–6 cm, with hypertrophied nerves throughout. Patient achieved spontaneous bowel movements post-procedure.
  • 15:13Hinman-Allen Syndrome and Outcome — Urology consultation diagnosed Hinman-Allen syndrome: non-neurogenic neurogenic bladder from voluntary pelvic floor contraction, prevalent in trisomy 21 adolescents. Managed with intermittent catheterization. Panel discusses whether Hirschsprung pull-through would have been preferable and long-term prognosis of myomectomy.

Key claims

  • 1:10Suction rectal biopsy adequacy requires sufficient submucosa depth, correct anatomic level (normal rectal mucosa, not transitional epithelium), assessment of nerve hypertrophy, cholinesterase staining, and calretinin staining. — Jack
  • 1:34In very short segment Hirschsprung disease, nerve hypertrophy may not be present. — Jack
  • 1:41Calretinin staining has become important in Hirschsprung diagnosis in recent years. — Jack
  • 2:25Gold standard for Hirschsprung diagnosis in infants is suction rectal biopsy; if inadequate, proceed to open transanal full-thickness rectal biopsy. — Kristine Thayer
  • 3:02The transanal rectal biopsy at 3 cm above the dentate line showed hypertrophied nerve bundles and abnormal calretinin with lack of significant fiber staining in the mucosa, consistent with short segment Hirschsprung disease. — Kristine Thayer
  • 3:41Barium enema on unprepped bowel showed no distinctive transition zone. — Kristine Thayer
  • 4:41Transanal rectal biopsies at 5, 6, and 7 cm and laparoscopic biopsies at peritoneal reflection, rectosigmoid, proximal and distal sigmoid, and distal descending colon all returned normal. — Kristine Thayer
  • 5:21In 16-year-olds with new diagnosis of Hirschsprung disease, the colon is almost always very dilated. — Jack
  • 5:36In older children with dilated colon, typical approach is to perform a diverting stoma for approximately six months to decompress the colon, followed by a Duhamel procedure. — Jack
  • 5:49Pulling a dilated rectum through the anus using a transanal technique requires excessive stretching of the sphincter, which should be avoided. — Jack
  • 6:49The patient was stooling only twice per month on MiraLAX. — Bob
  • 7:47It is difficult to explain stooling only twice per month with a colon appearance like this if the obstruction is truly at the anus. — Bob
  • 8:09Botox is not a good treatment for established Hirschsprung disease; it is appropriate for obstructive symptoms after pull-through when the sphincter is not relaxing normally. — Jack
  • 8:33Botox injection could serve as a diagnostic test: significant improvement after injection would support proceeding with surgical intervention in a case with conflicting findings. — Sharif
  • 9:40The patient had a nearly 2-liter neurogenic bladder and was experiencing overflow incontinence rather than true voiding. — Kristine Thayer
  • 11:48If a biopsy at 3 cm in an average 16-year-old showed the findings described, it would be abnormal; normal ganglion cells would be expected. — Jack
  • 11:57In straightforward cases with a positive suction rectal biopsy showing all findings of Hirschsprung disease, a repeat low biopsy in the operating room is not routinely performed. — Speaker 3
  • 12:29In confusing cases, repeat biopsies at the same low level have sometimes returned normal when the initial biopsy was positive, leading to abortion of the operation. — Speaker 3
  • 13:44A strip myomectomy specimen (22 cm width × 6 cm length of posterior submucosa) showed no ganglion cells from the anal verge to 2 cm, sparse ganglion cells from 2 to 4 cm, normal ganglion cells from 4 to 6 cm, hypertrophied nerve bundles throughout the entire specimen including at 6 cm, and abnormal calretinin only in the distal 2 cm. — Kristine Thayer
  • 14:46After the myomectomy, the patient was able to stool spontaneously. — Kristine Thayer
  • 15:13Hinman-Allen syndrome is a non-neurogenic neurogenic bladder resulting from voluntary contraction of pelvic floor muscles, causing both constipation and urinary retention to the point where the bladder becomes neurogenic. — Kristine Thayer
  • 15:13Hinman-Allen syndrome is very prevalent in trisomy 21 adolescents and is a learned behavior that can be overcome with intermittent catheterization. — Kristine Thayer
  • 16:19Anorectal manometry in a cooperative 16-year-old could have determined whether the patient physiologically had Hirschsprung disease and would have allowed suspicion of the pathology results. — Speaker 6
  • 16:44The patient was very combative and noncompliant, making anorectal manometry impractical. — Kristine Thayer
  • 16:53This patient had Hirschsprung disease and would have done well with a Hirschsprung operation (Duhamel). — Jack
  • 17:00Myomectomy for short segment Hirschsprung patients often does not have long-term success; patients often have more obstructive symptoms and higher risk of soiling because the myomectomy usually involves the sphincter. — Jack
  • 17:36Thyroid function was normal in this patient. — Kristine Thayer

Cases discussed

  • 0:0016-year-old with trisomy 21, lifelong constipation (stooling twice monthly on MiraLAX), no prior enterocolitis hospitalizations. Developed autism spectrum disorder and oppositional defiant disorder over preceding 18 months. Initial suction rectal biopsy showed absent ganglion cells; transanal biopsy at 3 cm confirmed Hirschsprung findings, but all higher biopsies were normal. Discovered to have 2-liter neurogenic bladder. Diagnosed with Hinman-Allen syndrome.

Points of disagreement

  • 16:53Optimal surgical approach for this patient
    • Jack: Patient had Hirschsprung disease and would have done well with a Duhamel procedure. Myomectomy for short segment Hirschsprung often lacks long-term success, with more obstructive symptoms and higher soiling risk due to sphincter involvement.
    • Kristine Thayer: Performed myomectomy given conflicting pathology, discovery of Hinman-Allen syndrome, and concern that a major pull-through procedure might not address the underlying functional disorder. Patient achieved spontaneous bowel movements post-myomectomy.
  • 7:59Role of Botox injection in this case
    • Sharif: Botox injection would be useful diagnostically: significant improvement would support proceeding with major surgical intervention in a case with conflicting findings and other reasons for constipation.
    • Jack: Botox is not a good treatment for established Hirschsprung disease; it is appropriate for post-pull-through sphincter dysfunction, not for primary diagnosis or treatment.

Open questions

  • What is the appropriate definition of ultra-short or short segment Hirschsprung disease in a 16-year-old, given that anatomic measurements from newborns may not apply?
  • Should anorectal manometry be routinely performed in adolescents with suspected Hirschsprung disease when pathology is conflicting?
  • What is the long-term functional outcome of posterior myomectomy for ultra-short segment Hirschsprung disease compared to formal pull-through procedures?
  • In cases with discordant pathology (positive low biopsy, normal higher biopsies), should a repeat biopsy at the original low level be performed intraoperatively before proceeding with definitive surgery?
  • How should the presence of Hinman-Allen syndrome influence surgical decision-making in a patient with pathologic evidence of Hirschsprung disease?
This episode was analyzed and enriched by Kai, the Library's AI content creator. Every item links to the moment it comes from — click a timestamp to listen in context.
Written for:

Ultra-Short Segment Hirschsprung Disease: When Pathology and Clinical Picture Diverge

The episode's main topic retold as a plain-language walkthrough — what it is, why it matters, and what the speakers concluded. Written by Kai from the episode transcript and reviewed before publishing.

For the care team · Explainer · AI-written, human-reviewed

Why This Diagnosis Exists

Hirschsprung disease — congenital absence of ganglion cells in the distal bowel — typically presents in infancy with failure to pass meconium or early-onset constipation. The aganglionic segment extends from the anus proximally, most commonly involving the rectosigmoid. In classic cases, the transition zone is visible on contrast enema and the diagnosis is straightforward. Ultra-short segment disease, where aganglionosis is confined to the distal 2–4 cm of rectum, exists at the diagnostic margin. The colon above looks normal. The contrast study shows no transition. The clinical picture is ambiguous. These patients force the question: when does pathologic aganglionosis constitute functional Hirschsprung disease?

The Core Clinical Problem

A 16-year-old with trisomy 21 presented with lifelong constipation, stooling only twice monthly despite laxatives 6:49. Initial suction rectal biopsy showed no ganglion cells, but adequacy was uncertain — in adolescents, suction biopsies rarely capture sufficient submucosa 1:10. Transanal full-thickness biopsy at 3 cm confirmed hypertrophied nerves and abnormal calretinin staining, consistent with Hirschsprung disease 3:02. Yet the barium enema showed no transition zone 3:41, and the colon appeared surprisingly normal for a 16-year-old with such severe symptoms 5:21. Higher biopsies — transanal at 5, 6, 7 cm and laparoscopic samples throughout the left colon — all returned normal 4:41.

The discrepancy was stark: pathology said Hirschsprung, but the clinical picture did not fit. One discussant noted the difficulty of reconciling such severe constipation with an obstruction confined to the distal rectum in a colon showing no proximal dilation 7:47. The patient's symptoms seemed disproportionate to a 3 cm aganglionic segment.

Diagnostic Approach and Pitfalls

A suction rectal biopsy is adequate only if it meets multiple criteria: sufficient submucosa depth, correct anatomic level (normal rectal mucosa, not transitional epithelium near the dentate line), assessment for nerve hypertrophy, cholinesterase staining, and calretinin staining 1:10. Calretinin has become particularly important in recent years 1:41. In very short segment disease, nerve hypertrophy may be absent 1:34, making histochemical staining essential.

When initial pathology is positive but the clinical picture is confusing, repeat biopsy at the same low level can yield different results. In some cases, a second biopsy has returned normal when the first showed Hirschsprung findings, leading to abortion of planned pull-through procedures 12:29. This is not sampling error — it reflects the patchy distribution of ganglion cells at the transition zone in ultra-short segment disease.

One discussant proposed Botox injection as a diagnostic test: significant symptomatic improvement after sphincter injection would support proceeding with definitive surgery in a case with conflicting findings 8:33. This is distinct from using Botox therapeutically, which is appropriate for post-pull-through sphincter dysfunction but not for established Hirschsprung disease 8:09.

The Confounding Factor

During inpatient workup, the patient was found to have a nearly 2-liter neurogenic bladder with overflow incontinence 9:40. Urology diagnosed Hinman-Allen syndrome: a non-neurogenic neurogenic bladder resulting from voluntary pelvic floor contraction, causing both urinary retention and constipation severe enough to render the bladder neurogenic 15:13. The condition is prevalent in adolescents with trisomy 21 and represents a learned behavior manageable with intermittent catheterization 15:13. The patient's noncompliance precluded anorectal manometry, which might have clarified whether he had physiologic Hirschsprung disease 16:19.

Surgical Resolution and Pathologic Findings

The surgeon performed a posterior strip myomectomy, excising a specimen of posterior submucosa for continuous pathologic assessment from the anal verge proximally 13:44. This provided both diagnosis and treatment. Pathology showed a gradient: no ganglion cells from verge to 2 cm, sparse ganglion cells from 2–4 cm, normal ganglion cells from 4–6 cm, with hypertrophied nerve bundles throughout the entire specimen and abnormal calretinin only in the distal 2 cm 13:44. After myomectomy, the patient achieved spontaneous bowel movements 14:46.

The Contested Question

Did this patient have Hirschsprung disease requiring pull-through, or ultra-short segment pathology that could be managed with myomectomy? One discussant argued the patient had Hirschsprung disease and would have done well with a Duhamel procedure 16:53. The concern with myomectomy is durability: these patients often develop recurrent obstructive symptoms and higher soiling rates because the myomectomy involves the sphincter 17:00. In a typical 16-year-old, a biopsy at 3 cm would show normal ganglion cells; finding Hirschsprung pathology at that level is abnormal 11:48.

The counterargument: this patient had Hinman-Allen syndrome driving both bladder and bowel dysfunction. Performing a major pull-through operation might not have addressed the underlying pelvic floor dysfunction and could have resulted in worse functional outcomes.

When to Involve Pediatric Surgery

Refer adolescents with severe, lifelong constipation unresponsive to medical management, particularly those with trisomy 21 or other risk factors for Hirschsprung disease. Refer earlier if there is failure to thrive, abdominal distension, or enterocolitis. In adolescents, the diagnosis is more complex than in infants — expect ambiguous imaging, consider pelvic floor dysfunction as a confounding factor, and recognize that pathology alone may not dictate surgical approach. Anorectal manometry, when feasible, can clarify whether functional obstruction is present. The goal is not simply to confirm aganglionosis but to determine whether the patient has physiologic Hirschsprung disease that will respond to pull-through.

Takeaways from this story

  • Ultra-short segment Hirschsprung may show normal colon appearance on imaging despite severe constipation, creating diagnostic ambiguity.
  • Repeat biopsy at the same low rectal level can yield different results in ultra-short segment disease due to patchy ganglion cell distribution.
  • Hinman-Allen syndrome — voluntary pelvic floor contraction causing neurogenic bladder — is prevalent in adolescents with trisomy 21 and mimics Hirschsprung.
  • Strip myomectomy provides continuous pathologic assessment but may have worse long-term functional outcomes than definitive pull-through.
  • Anorectal manometry can clarify whether functional obstruction is present when clinical and pathologic findings conflict.

Keywords

Hashtags

Transcript

Comments

Loading comments…